Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer
暂无分享,去创建一个
[1] Martin Hermansson,et al. Automated quantitative analysis of complex lipidomes by liquid chromatography/mass spectrometry. , 2005, Analytical chemistry.
[2] R. Kostiainen,et al. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. , 2001, Journal of lipid research.
[3] Dukjin Kang,et al. Nanoflow liquid chromatography-tandem mass spectrometry for the characterization of intact phosphatidylcholines from soybean, bovine brain, and liver. , 2006, Journal of chromatography. A.
[4] V. Zaremberg,et al. Cell membranes and apoptosis: role of cardiolipin, phosphatidylcholine, and anticancer lipid analogues. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[5] S. Moss,et al. Annexins: linking Ca2+ signalling to membrane dynamics , 2005, Nature Reviews Molecular Cell Biology.
[6] Xianlin Han,et al. Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry , 1995, Journal of the American Society for Mass Spectrometry.
[7] John T. Wei,et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.
[8] Rebecca Sutphen,et al. Lysophospholipids are potential biomarkers of ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] R. Taguchi,et al. Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. , 2000, Journal of mass spectrometry : JMS.
[10] Robert A. Gardiner,et al. Markers for Detection of Prostate Cancer , 2010, Cancers.
[11] P. Carroll,et al. Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues , 2003, Magnetic resonance in medicine.
[12] Takao Shimizu,et al. Focused lipidomics by tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] Y. Fujimoto,et al. Clinical application of basic arginine amidase in human male urine. , 1996, Biological and Pharmaceutical Bulletin.
[14] J. Brouwers,et al. Rapid separation and identification of phosphatidylethanolamine molecular species. , 1999, Journal of Lipid Research.
[15] G. Kong,et al. Quantitative analysis of phosphatidylcholines and phosphatidylethanolamines in urine of patients with breast cancer by nanoflow liquid chromatography/tandem mass spectrometry , 2009, Analytical and bioanalytical chemistry.
[16] K. Markides,et al. Analysis of phosphatidylcholine and sphingomyelin molecular species from brain extracts using capillary liquid chromatography electrospray ionization mass spectrometry , 2003, Journal of Neuroscience Methods.
[17] L. Salomon,et al. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection. , 2005, Urology.
[18] T. Powles,et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment , 1998, NMR in biomedicine.
[19] M. Moon,et al. Profiling of human urinary phospholipids by nanoflow liquid chromatography/tandem mass spectrometry. , 2008, The Analyst.
[20] M Markman,et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.
[21] C. Couet,et al. Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma , 1991, Breast Cancer Research and Treatment.
[22] B. Chung,et al. Quantitative analysis of phosphatidylcholine in rat liver tissue by nanoflow liquid chromatography/tandem mass spectrometry. , 2007, Journal of separation science.
[23] G. Kong,et al. Quantitative analysis of urinary phospholipids found in patients with breast cancer by nanoflow liquid chromatography–tandem mass spectrometry: II. Negative ion mode analysis of four phospholipid classes , 2010, Analytical and bioanalytical chemistry.
[24] C. Williams,et al. Fatty acid compositions of inositol and choline phospholipids of breast tumours and normal breast tissue. , 1993, European journal of clinical nutrition.
[25] S. Devesa,et al. Trends and patterns of prostate cancer: what do they suggest? , 2001, Epidemiologic reviews.
[26] M. Moon,et al. Shotgun analysis of phospholipids from mouse liver and brain by nanoflow liquid chromatography/tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[27] Henrik Grönberg,et al. Prostate cancer epidemiology , 2003, The Lancet.